dengyuepharma

dengyuepharma agregó una foto Fitness
2026-01-13 08:34:05 - Translate

Tenofovir Amibufenamide, a rising star in chronic hepatitis B treatment: How to achieve significant therapeutic effects with low dosage?
2026-01-13 Written by DengyueMed Tenofovir Amibufenamide (Hengmu®) is a next-generation tenofovir prodrug independently developed in China for the treatment of chronic hepatitis B (CHB). Designed with optimized molecular structure and enhanced liver targeting, Tenofovir Amibufenamide delivers potent antiviral efficacy at a significantly lower dose, while offering a favorable long-term...

0 Commentarios 0 Acciones 4K Views 0 Vista previa

Please log in to like, share and comment!
dengyuepharma agregó una foto Fitness
2026-01-07 08:48:23 - Translate

Trastuzumab Botidotin: Ushering HER2-Targeted Therapy into a New Era of Dual-Epitope Synergy
As precision oncology continues to advance, HER2 (human epidermal growth factor receptor 2) has become one of the most mature and clinically valuable therapeutic targets across multiple solid tumors. With an improved understanding of tumor heterogeneity and mechanisms of drug resistance, the limitations of single-target, single-mechanism treatment strategies have become increasingly evident....

0 Commentarios 0 Acciones 968 Views 0 Vista previa

Please log in to like, share and comment!
dengyuepharma updated the profile picture
2026-01-06 09:24:21 - Translate

0 Commentarios 0 Acciones 678 Views 0 Vista previa

Please log in to like, share and comment!